Bobby Boursiquot

Bobby Boursiquot has a strong background in quality assurance, regulatory affairs, and business development in the pharmaceutical industry. Bobby began their career as a Technician in Analytical Services at Warnex in 2001, where they gained experience in chromatography. Bobby then moved to Labopharm in 2006 and worked as an Analyst II in Analytical Services and later as an Analyst III in Galenic Development. In 2009, they joined BioEnvelop/Paladin Labs as a Manager in Quality Control and Analytical Development.

In 2010, Bobby joined Pharmetics Inc. as a Supervisor in Quality Control and eventually progressed to become a Project Manager for natural health products and over-the-counter drugs. Bobby then took on the role of Team Leader in Portfolio and Project Management, and later became the Director of Quality Assurance and Regulatory Affairs.

In 2017, Bobby had a brief stint as the President of Rapido Cuisto! before joining LaboVal Inc. as the Director of Quality Assurance. Bobby transitioned to the role of Director of Business Development at Neopharm Labs in 2018, where they currently hold the position.

Bobby Boursiquot began their education in 1998 at Collège Ahuntsic, where they pursued a D.E.C. in Techniques de Chimie analytique. Bobby completed this program in 2001. Subsequently, from 2002 to 2006, Bobby attended Concordia University, where they obtained a B.Sc. degree in Chemistry. Afterward, they enrolled at HEC Montréal, where they pursued a Certificate in Business Management from 2006 to 2009. In 2011, Bobby started their MBA studies at UQAM | Université du Québec à Montréal. The end year for their MBA is not specified in the provided information.